PROFUND ADVISORS LLC

Position in KURA — Kura Oncology, Inc.

CIK 1129919 BETHESDA, MD

Position in KURA

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$487,133

-$231,065 QoQ

Shares Held

59,918

-13.3% QoQ

Ownership

0.067%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,565,563 across 158 Biotechnology names. KURA ranks #96 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,137	$10,331,595
2	REGN	Regeneron Pharmaceuticals, Inc.	10,332	$7,982,916
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,647	$4,846,252
4	INSM	INSMED Inc	27,937	$4,568,258
5	APLS	Apellis Pharmaceuticals, Inc.	81,190	$3,266,273
6	MDGL	Madrigal Pharmaceuticals, Inc.	4,862	$2,545,111
7	TGTX	Tg Therapeutics, Inc.	76,039	$2,526,015
8	ARWR	Arrowhead Pharmaceuticals, Inc.	39,758	$2,492,826

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$487,133	59,918	-13.3%	Shares	Sole	2026-04-27
2025-12-31	$718,198	69,124	+178.3%	Shares	Sole	2026-02-06
2025-09-30	$219,789	24,835	+11.1%	Shares	Sole	2025-11-06
2025-06-30	$128,999	22,357	-18.2%	Shares	Sole	2025-08-07
2025-03-31	$180,338	27,324	-3.6%	Shares	Sole	2025-05-08
2024-12-31	$246,998	28,358	+50.3%	Shares	Sole	2025-02-14
2024-09-30	$368,680	18,868	-19.9%	Shares	Sole	2024-11-14
2024-06-30	$485,244	23,567	-51.6%	Shares	Sole	2024-08-13
2024-03-31	$1,038,387	48,682	+90.3%	Shares	Sole	2024-05-08
2023-12-31	$367,955	25,588	-35.4%	Shares	Sole	2024-02-14
2023-09-30	$361,343	39,621	+8.9%	Shares	Sole	2023-11-13
2023-06-30	$385,037	36,393	-28.9%	Shares	Sole	2023-08-10
2023-03-31	$625,833	51,172	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.